These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 7682315

  • 1. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
    Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A.
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):675-8. PubMed ID: 7682315
    [Abstract] [Full Text] [Related]

  • 2. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.
    Rudnicka AR, Wald NJ, Huttly W, Hackshaw AK.
    Prenat Diagn; 2002 Oct; 22(10):893-7. PubMed ID: 12378572
    [Abstract] [Full Text] [Related]

  • 3. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL.
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [Abstract] [Full Text] [Related]

  • 4. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K, Bindra R, Cacho AM, Nicolaides KH.
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [Abstract] [Full Text] [Related]

  • 5. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA.
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [Abstract] [Full Text] [Related]

  • 6. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE.
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [Abstract] [Full Text] [Related]

  • 7. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ, Watt HC.
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [Abstract] [Full Text] [Related]

  • 8. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
    Heyl PS, Miller W, Canick JA.
    Obstet Gynecol; 1990 Dec; 76(6):1025-31. PubMed ID: 1700348
    [Abstract] [Full Text] [Related]

  • 9. Effect of gravidity on maternal serum markers for Down's syndrome.
    Barkai G, Goldman B, Ries L, Chaki R, Cuckle H.
    Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805
    [Abstract] [Full Text] [Related]

  • 10. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Apr; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 11. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
    MacDonald ML, Wagner RM, Slotnick RN.
    Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
    [Abstract] [Full Text] [Related]

  • 12. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
    Huttly W, Rudnicka A, Wald NJ.
    Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
    [Abstract] [Full Text] [Related]

  • 13. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT.
    CMAJ; 1996 Feb 15; 154(4):465-79. PubMed ID: 8630836
    [Abstract] [Full Text] [Related]

  • 14. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S, Wang Y, Ye G.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov 15; 32(11):655-8. PubMed ID: 9639764
    [Abstract] [Full Text] [Related]

  • 15. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD, McIntosh SF, Halstead AC.
    Prenat Diagn; 2005 Mar 15; 25(3):234-8. PubMed ID: 15791658
    [Abstract] [Full Text] [Related]

  • 16. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
    Christiansen M, Høgdall EV, Larsen SO, Høgdall C.
    Prenat Diagn; 2002 May 15; 22(5):385-7. PubMed ID: 12001192
    [Abstract] [Full Text] [Related]

  • 17. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection].
    Christiansen M, Larsen SO, Nørgaard-Pedersen B.
    Lakartidningen; 1997 Dec 17; 94(51-52):4898-902. PubMed ID: 9454010
    [Abstract] [Full Text] [Related]

  • 18. Triploidy identified through second-trimester serum screening.
    Huang T, Alberman E, Wald N, Summers AM.
    Prenat Diagn; 2005 Mar 17; 25(3):229-33. PubMed ID: 15791661
    [Abstract] [Full Text] [Related]

  • 19. The detection of non-immune hydrops through second-trimester maternal serum screening.
    Saller DN, Canick JA, Oyer CE.
    Prenat Diagn; 1996 May 17; 16(5):431-5. PubMed ID: 8844001
    [Abstract] [Full Text] [Related]

  • 20. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.
    Zhang J, Lambert-Messerlian G, Palomaki GE, Canick JA.
    Prenat Diagn; 2011 Jun 17; 31(6):583-8. PubMed ID: 21480302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.